top of page

Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection

Pfizer Inc. (NYSE:PFE) today announced an award of a grant from the Bill & Melinda Gates Foundation to conduct a Phase 1/2 clinical trial of Pfizer's vaccine candidate against group B Streptococcus(group B strep or GBS) infection, a leading cause of neonatal sepsis, a serious life-threatening blood infection.


READ MORE

source: http://www.worldpharmanews.com/pfizer/3669-pfizer-awarded-grant-to-evaluate-vaccine-to-protect-newborns-against-group-b-streptococcus-infection




#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page